[Relation between dose, plasma concentration and therapeutic effect of theophylline in children with sleep apnea].
The plasma concentration of theophylline was determined in twelve children with infantile sleep apnea (average age 48.5 days). The purpose of the study was to correlate concentrations with the dosages given, the therapeutic response and any adverse effects which could arise. In addition, other pharmacokinetic values were found, half-life (t 1/2) and clearance concentrations (Clss). The oral maintenance dose used was 4 mg/kg/24 h. The serum concentration of theophylline was determined by a homogeneous immunoassay enzyme technique (EMIT). A bad correlation was found (r = 0.45) between the oral dosage given and the plasma concentrations found. This was probably due to variations in the clearance of the drug. Yet, plasma concentrations fell between 3.0 and 12.6 micrograms/mL, enough to satisfactorily control apneic episodes in all the children included in the study without undesirable side-effects. Only one patient had some trouble in falling asleep and showed signs of irritability. The half-life was 13.30 +/- 7.46 hours and Clss was 36.64 +/- 12.98 mL/h/kg. In general, our results correlate with those reported in the literature. The accuracy of the pharmacokinetic parameters with two samples is reliable, therefore avoiding the use of multiple sampling in this group of children.
Rodríguez-Palomares
C
C
Ugartechea
J C
JC
Palma-Aguirre
J A
JA
Juárez-Olguín
H
H
Calderón-Mandujano
B
B
D004305:Dose-Response Relationship, Drug; D005260:Female; D006801:Humans; D007223:Infant; D007231:Infant, Newborn; D008297:Male; D012891:Sleep Apnea Syndromes / Q000188:drug therapy*; D013806:Theophylline / Q000008:administration & dosage / Q000097:blood / Q000627:therapeutic use*
D013806:Theophylline
Relación entre la dosis, concentración plasmática y efecto terapéutico de teofilina en niños con apnea del sueño.